Lung Cancer
Volume 76, Issue 3 , Pages 478-485 , June 2012

Benefits and risks of using erythropoiesis-stimulating agents (ESAs) in lung cancer patients: Study-level and patient-level meta-analyses

  • Johan Vansteenkiste

      Affiliations

    • Respiratory Oncology Unit (Pulmonology), University Hospital Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium
    • Corresponding Author InformationCorresponding author. Tel.: +32 16346801; fax: +32 16346803.
    web address
  • ,
  • John Glaspy

      Affiliations

    • Hematology and Oncology, University of California at Los Angeles, Los Angeles, CA, USA
  • ,
  • David Henry

      Affiliations

    • Department of Medicine, Pennsylvania Hospital, Philadelphia, PA 19106, USA
  • ,
  • Heinz Ludwig

      Affiliations

    • First Department of Medicine, Center for Oncology and Hematology, Wilhelminenspital, Vienna, Austria
  • ,
  • Robert Pirker

      Affiliations

    • Department of Medicine I, Medical University Vienna, Vienna, Austria
  • ,
  • Dianne Tomita

      Affiliations

    • Global Biostatistics, Amgen Inc., Thousand Oaks, CA, USA
  • ,
  • Helen Collins

      Affiliations

    • Clinical Research, Hematology/Oncology, Amgen Inc., Thousand Oaks, CA, USA
  • ,
  • Jeffrey Crawford

      Affiliations

    • Department of Medicine, Duke University Medical Center, Durham, NC, USA

Received 29 September 2011 ,Revised 20 December 2011 ,Accepted 27 December 2011.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0169-5002(11)00679-9

doi: 10.1016/j.lungcan.2011.12.015

Lung Cancer
Volume 76, Issue 3 , Pages 478-485 , June 2012